Cargando…

Prevalence of metabolic syndrome in Iran: A meta-analysis

BACKGROUND: Metabolic syndrome) MetS( is a complex risk factor which increases the risk of cardiovascular diseases and type 2 diabetes. There are many studies with various populations and results about the prevalence of MetS in Iran; in order to authenticate these studies and have an overall estimat...

Descripción completa

Detalles Bibliográficos
Autores principales: Ostovar, Rahim, Kiani, Faezeh, Sayehmiri, Fatemeh, Yasemi, Masood, Mohsenzadeh, Yazdan, Mohsenzadeh, Yousof
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Electronic physician 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5718841/
https://www.ncbi.nlm.nih.gov/pubmed/29238477
http://dx.doi.org/10.19082/5402
_version_ 1783284395599200256
author Ostovar, Rahim
Kiani, Faezeh
Sayehmiri, Fatemeh
Yasemi, Masood
Mohsenzadeh, Yazdan
Mohsenzadeh, Yousof
author_facet Ostovar, Rahim
Kiani, Faezeh
Sayehmiri, Fatemeh
Yasemi, Masood
Mohsenzadeh, Yazdan
Mohsenzadeh, Yousof
author_sort Ostovar, Rahim
collection PubMed
description BACKGROUND: Metabolic syndrome) MetS( is a complex risk factor which increases the risk of cardiovascular diseases and type 2 diabetes. There are many studies with various populations and results about the prevalence of MetS in Iran; in order to authenticate these studies and have an overall estimation of its prevalence in Iran, performing a meta-analysis seems to be necessary. OBJECTIVE: This study aimed to investigate the prevalence of MetS and its components in Iran via meta-analysis method. METHODS: All associated published papers in national and international journals of PubMed, Scopus, Web of Science, Magiran, Iranmedex, Science Direct, Medlib, and SID databases were searched from January, 2000 to October, 2016. All types of studies, including local and national surveys that reported the prevalence of MetS among healthy populations in Iran were reviewed. The effects of age, sample size and publication date as possible sources of heterogeneity among the study findings was examined by meta-regression. P-values less than 0.05 were considered as significant in heterogeneity tests. All analysis was done by R Ver. 3.2.1 and STATA (version 10). RESULTS: Seventy eligible studies were selected for meta-analysis. The overall estimation of MetS prevalence was 25% (95% CI: 22–29%) based on the Adult Treatment Panel III (ATP III) criteria, 30% (95% CI: 25–36%) according to the International Diabetes Federation (IDF), and 39% (95% CI: 26–52%) based on the Joint Interim Societies (JIS) criteria. The prevalence of MetS was lower in men than in women (26.9% versus 35.7%). The prevalence of various MetS components including High TG (triglyceride), Low HDL-C, High BP and High FBS (fasting blood sugar) was 43%, 54%, 38% and 22% among the adult population. CONCLUSION: Findings from the present meta-analyses study displayed a high prevalence of metabolic syndrome in Iran, especially in women, which increases with age in both sexes. It alerts health care providers and policy makers to find solutions in order to take action to reduce MetS risk in society.
format Online
Article
Text
id pubmed-5718841
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher Electronic physician
record_format MEDLINE/PubMed
spelling pubmed-57188412017-12-13 Prevalence of metabolic syndrome in Iran: A meta-analysis Ostovar, Rahim Kiani, Faezeh Sayehmiri, Fatemeh Yasemi, Masood Mohsenzadeh, Yazdan Mohsenzadeh, Yousof Electron Physician Meta-Analysis BACKGROUND: Metabolic syndrome) MetS( is a complex risk factor which increases the risk of cardiovascular diseases and type 2 diabetes. There are many studies with various populations and results about the prevalence of MetS in Iran; in order to authenticate these studies and have an overall estimation of its prevalence in Iran, performing a meta-analysis seems to be necessary. OBJECTIVE: This study aimed to investigate the prevalence of MetS and its components in Iran via meta-analysis method. METHODS: All associated published papers in national and international journals of PubMed, Scopus, Web of Science, Magiran, Iranmedex, Science Direct, Medlib, and SID databases were searched from January, 2000 to October, 2016. All types of studies, including local and national surveys that reported the prevalence of MetS among healthy populations in Iran were reviewed. The effects of age, sample size and publication date as possible sources of heterogeneity among the study findings was examined by meta-regression. P-values less than 0.05 were considered as significant in heterogeneity tests. All analysis was done by R Ver. 3.2.1 and STATA (version 10). RESULTS: Seventy eligible studies were selected for meta-analysis. The overall estimation of MetS prevalence was 25% (95% CI: 22–29%) based on the Adult Treatment Panel III (ATP III) criteria, 30% (95% CI: 25–36%) according to the International Diabetes Federation (IDF), and 39% (95% CI: 26–52%) based on the Joint Interim Societies (JIS) criteria. The prevalence of MetS was lower in men than in women (26.9% versus 35.7%). The prevalence of various MetS components including High TG (triglyceride), Low HDL-C, High BP and High FBS (fasting blood sugar) was 43%, 54%, 38% and 22% among the adult population. CONCLUSION: Findings from the present meta-analyses study displayed a high prevalence of metabolic syndrome in Iran, especially in women, which increases with age in both sexes. It alerts health care providers and policy makers to find solutions in order to take action to reduce MetS risk in society. Electronic physician 2017-10-25 /pmc/articles/PMC5718841/ /pubmed/29238477 http://dx.doi.org/10.19082/5402 Text en © 2017 The Authors This is an open access article under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs License (http://creativecommons.org/licenses/by-nc-nd/3.0/) , which permits use and distribution in any medium, provided the original work is properly cited, the use is non-commercial and no modifications or adaptations are made.
spellingShingle Meta-Analysis
Ostovar, Rahim
Kiani, Faezeh
Sayehmiri, Fatemeh
Yasemi, Masood
Mohsenzadeh, Yazdan
Mohsenzadeh, Yousof
Prevalence of metabolic syndrome in Iran: A meta-analysis
title Prevalence of metabolic syndrome in Iran: A meta-analysis
title_full Prevalence of metabolic syndrome in Iran: A meta-analysis
title_fullStr Prevalence of metabolic syndrome in Iran: A meta-analysis
title_full_unstemmed Prevalence of metabolic syndrome in Iran: A meta-analysis
title_short Prevalence of metabolic syndrome in Iran: A meta-analysis
title_sort prevalence of metabolic syndrome in iran: a meta-analysis
topic Meta-Analysis
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5718841/
https://www.ncbi.nlm.nih.gov/pubmed/29238477
http://dx.doi.org/10.19082/5402
work_keys_str_mv AT ostovarrahim prevalenceofmetabolicsyndromeiniranametaanalysis
AT kianifaezeh prevalenceofmetabolicsyndromeiniranametaanalysis
AT sayehmirifatemeh prevalenceofmetabolicsyndromeiniranametaanalysis
AT yasemimasood prevalenceofmetabolicsyndromeiniranametaanalysis
AT mohsenzadehyazdan prevalenceofmetabolicsyndromeiniranametaanalysis
AT mohsenzadehyousof prevalenceofmetabolicsyndromeiniranametaanalysis